Invenia ABUS 2.0

Look differently at dense breast tissue

GE Healthcare offers the first FDA-approved ultrasound supplemental technology that is specifically designed for detecting cancer in dense breast tissue. Compared to mammography alone, Invenia ABUS 2.0 imaging looks differently at dense breast tissue, providing a comprehensive view of the breast.